Page 193 - Small Animal Internal Medicine, 6th Edition
P. 193

CHAPTER 8   Myocardial Diseases of the Cat   165





  VetBooks.ir












                                              A

















                            B                                  C

                          FIG 8.6
                          (A) Color flow Doppler image taken in systole from a male domestic longhair cat with
                          hypertrophic obstructive cardiomyopathy. Note the turbulent flow just above where the
                          thickened interventricular septum protrudes into the LV outflow tract and a small mitral
                          insufficiency jet, typical with systolic anterior motion (SAM) of the anterior mitral leaflet.
                          (B) and (C) show two-dimensional and corresponding color Doppler images from a male
                          domestic shorthair cat with hypertrophic obstructive cardiomyopathy. There is hypertrophy
                          of the basilar interventricular septum and severe left atrial enlargement. The anterior mitral
                          leaflet’s SAM (arrow, B) contributes to dynamic LV outflow obstruction. (C) Color Doppler
                          imaging in midsystole reveals turbulent, high-velocity flow in the LV outflow tract and, in
                          this cat, severe mitral regurgitation. Right parasternal long-axis view. Ao, Aorta; LA, left
                          atrium; LV, left ventricle.




              Cats with severe pulmonary edema are given supplemen-  The use of pimobendan in cats with CHF is the subject of
            tal oxygen and parenteral furosemide, usually intramuscular   ongoing study. In theory, positive inotropes such as pimo-
            (IM) initially (2 mg/kg q1-4h; see Box 3.1, p. 62 and p. 65),   bendan are not indicated in cats with HCM, because systolic
            until an intravenous (IV) catheter can be placed without   function generally is well preserved and increased force of
            excessive stress to the cat. Butorphanol can be helpful to   contraction could worsen dynamic outflow tract obstruc-
            reduce anxiety that accompanies dyspnea and hospitaliza-  tion. However, pimobendan could improve cardiac output
            tion (see  Box 3.1). Nitroglycerin ointment can be used   without increasing myocardial oxygen demand, and its bal-
            (q4-6h), although no studies of its efficacy in this situation   anced vasodilatory properties might be beneficial in both
            have been done. Once initial medications have been given,   acute and chronic CHF regardless of underlying structural
            the cat should be allowed to rest. The respiratory rate is noted   disease. Nevertheless, great caution is advised when HOCM
            initially and then every 15 to 30 minutes or so without dis-  is suspected or confirmed, because vasodilation, especially
            turbing the cat. Respiratory rate and effort are used to guide   combined with increased contractility, could worsen the
            ongoing diuretic therapy. Catheter placement, blood sam-  dynamic LV outflow obstruction and promote hypotension.
            pling, radiographs, and other tests and therapies should be   If pimobendan is used in a cat with HOCM, blood pressure
            delayed until the cat’s condition is more stable. Airway suc-  measurement and close monitoring for signs of hypotension
            tioning and mechanical ventilation with positive end-  are advised. Pimobendan is clearly indicated in cats with sys-
            expiratory pressure can be considered in extreme cases.  tolic dysfunction or cardiogenic shock, and several studies
   188   189   190   191   192   193   194   195   196   197   198